{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:14:11Z","timestamp":1790399651978,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Haemophilus influenzae serotype b (Hib) is an important cause of serious, invasive infections, particularly in young children. Since 1985, a series of vaccines composed of the type b capsular polysaccharide polyribosylribitol phosphate (PRP), followed by PRP conjugated to various proteins, have been licensed for use in the United States and worldwide. The conjugated vaccines offer increased immunogenicity and prolonged durability of immune protection compared to the plain PRP vaccine and increasingly are combined with other childhood vaccines for decreased cost and increased ease of vaccination. Hib vaccines have a very favorable safety profile, have been found to be either cost-saving or cost-effective by many public health agencies, and, in most countries, are initiated during early infancy as part of routine childhood immunization programs. As a result of widespread use of the vaccines, the incidence of Hib infections, and their associated morbidity and mortality, has fallen dramatically across the globe. Yet, many children remain unimmunized or underimmunized against Hib, particularly in limited-resource countries. Future efforts to further reduce the disease burden of Hib infections remain a high priority.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa537","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T03:31:38Z","timestamp":1597980698000},"page":"S321-S330","source":"Crossref","is-referenced-by-count":67,"title":["Hib Vaccines: Their Impact on <i>Haemophilus influenzae<\/i> Type b Disease"],"prefix":"10.1093","volume":"224","author":[{"given":"Janet R","family":"Gilsdorf","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"2021093008010254700_CIT0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/314535","article-title":"Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia","volume":"179","author":"Peltola","year":"1999","journal-title":"J Infect Dis"},{"key":"2021093008010254700_CIT0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/INF.0b013e3181ef25f7","article-title":"Long-term sequelae of childhood bacterial meningitis: an underappreciated problem","volume":"30","author":"Chandran","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"2021093008010254700_CIT0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"key":"2021093008010254700_CIT0029","first-page":"1","article-title":"Prevention and control of Haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63(RR-01)","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"2021093008010254700_CIT0041","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1016\/j.vaccine.2017.06.063","article-title":"New perspectives for hexavalent vaccines","volume":"36","author":"Obando-Pacheco","year":"2018","journal-title":"Vaccine"},{"key":"2021093008010254700_CIT0042","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.epirev.a036066","article-title":"The epidemiology and prevention of disease caused by Haemophilus influenzae type b","volume":"13","author":"Shapiro","year":"1991","journal-title":"Epidemiol Rev"},{"key":"2021093008010254700_CIT0051","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/INF.0b013e3182a14e57","article-title":"Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data","volume":"32","author":"Jackson","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2021093008010254700_CIT0054","author":"World Health Organization","year":"2019"},{"key":"2021093008010254700_CIT0056","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"2021093008010254700_CIT0066","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/cid\/ciy187","article-title":"Current epidemiology and trends in invasive Haemophilus influenzae disease\u2014United States, 2009-2015","volume":"67","author":"Soeters","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021093008010254700_CIT0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14760584.2017.1383157","article-title":"A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines","volume":"16","author":"Wang","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2021093008010254700_CIT0083","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jpeds.2013.03.022","article-title":"Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally","volume":"163","author":"Hajjeh","year":"2013","journal-title":"J Pediatr"},{"key":"2021093008010254700_CIT0115","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2012.11.035","article-title":"The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the Gavi Alliance","volume":"31(Suppl 2)","author":"Lee","year":"2013","journal-title":"Vaccine"},{"key":"2021093008010254700_CIT0128","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/13696998.2017.1359181","article-title":"Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review","volume":"20","author":"Chongmelaxme","year":"2017","journal-title":"J Med Econ"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_4\/S321\/40481487\/jiaa537.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_4\/S321\/40481487\/jiaa537.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:01:46Z","timestamp":1632988906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_4\/S321\/6378086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":14,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2021,9,30]]},"published-print":{"date-parts":[[2021,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa537","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,9,30]]}}}